Alkermes (ALKS)
Create an Alert
28.92
-0.99 -3.31%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Alkermes Cash from Investing Quarterly:
-111.83M for March 31, 2013Alkermes Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -111.83M |
| Dec. 31, 2012 | -31.30M |
| Sept. 30, 2012 | 65.64M |
| June 30, 2012 | 9.35M |
| March 31, 2012 | -21.58M |
| Dec. 31, 2011 | -2.528M |
| Sept. 30, 2011 | -399.88M |
| June 30, 2011 | 6.824M |
| March 31, 2011 | -11.50M |
| Dec. 31, 2010 | -11.92M |
| Sept. 30, 2010 | 0.231M |
| June 30, 2010 | 28.82M |
| March 31, 2010 | 8.505M |
| Dec. 31, 2009 | 20.40M |
| Sept. 30, 2009 | 17.12M |
| June 30, 2009 | -18.02M |
| March 31, 2009 | 44.48M |
| Dec. 31, 2008 | -4.812M |
| Sept. 30, 2008 | 8.555M |
| June 30, 2008 | -2.858M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
ALKS Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Alexion Pharmaceuticals | -5.569M |
| Anika Therapeutics | 0.0998M |
| AEterna Zentaris | -0.022M |
ALKS Cash from Investing Quarterly Rankings
| Overall |
57th percentile 7131 of 16782 |
| Sector |
42nd percentile 810 of 1410 in Healthcare |
| Industry |
33rd percentile 300 of 454 in Biotechnology |
ALKS Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -399.88M | Sep 2011 |
| Maximum | 65.64M | Sep 2012 |
| Average | -20.32M |
